Radiolabeled unconjugated bilirubin (UCB) is currently prepared by biosynth
etic labeling of bilirubin in fistula bile from precursor-labeled delta -am
inolevulinic acid (ALA) in rats or dogs. With existing methods, yields of l
abeled UCB from the bile are generally less than 50%. We here report modifi
cations of the original method of Ostrow et al (Ostrow JD: Hammaker L, Schm
id R. The preparation of crystalline bilirubin-C-14. J Clin invest 1961;40:
1442-52) that result in improvement of yields to 72% from both dog and rat
bile. The modifications include the initial deproteination of bile with a
reverse-phase C18 cartridge, removal of ethanol before alkaline hydrolysis
to avoid esterification of UCB, and adjustments for the high proportion of
non-glucuronide UCB conjugates in dog bile not precipitated as lead salts.
These improvements should save significantly on both costs and animal usage
.